Binding of Influenza A Virus NS1 Protein to DsRNA in Vitro

Overview

Journal J Gen Virol

Specialty Microbiology

Date 1992 Dec 1

PMID 1469370

Citations 89

Authors

E Hatada

R Fukuda

Affiliations

Soon will be listed here.

Abstract

The non-structural protein NS1 of influenza A virus exhibits two modes of RNA-binding activity. One is sequence-specific binding to minus-sense virus RNA with either a 5'- or 3'-terminal common sequence as reported previously. The other was identified as binding to dsRNA and this activity did not show sequence specificity. The affinity of binding to dsRNA was much higher than that to ssRNA. A short miniature virion RNA forming a panhandle structure by pairing between the 5'- and 3'-terminal common sequences bound NS1 with higher affinity and stability than did a dsRNA of similar sequence and length.

Citing Articles

Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity.

Rathnasinghe R, Chang L, Pearl R, Jangra S, Aspelund A, Hoag A NPJ Vaccines. 2024; 9(1):169.

PMID: 39300090 PMC: 11413010. DOI: 10.1038/s41541-024-00952-7.

Research progress on the nonstructural protein 1 (NS1) of influenza a virus.

Zhang X, Zhang Y, Wei F Virulence. 2024; 15(1):2359470.

PMID: 38918890 PMC: 11210920. DOI: 10.1080/21505594.2024.2359470.

Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.

Otter C, Renner D, Fausto A, Tan L, Cohen N, Weiss S Proc Natl Acad Sci U S A. 2024; 121(21):e2402540121.

PMID: 38758698 PMC: 11127059. DOI: 10.1073/pnas.2402540121.

Interferon signaling in the nasal epithelium distinguishes among lethal and common cold respiratory viruses and is critical for viral clearance.

Otter C, Renner D, Fausto A, Tan L, Cohen N, Weiss S bioRxiv. 2024; .

PMID: 38187597 PMC: 10769301. DOI: 10.1101/2023.12.18.571720.

Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy.

Marsili G, Acchioni C, Remoli A, Amatore D, Sgarbanti R, De Angelis M Int J Mol Sci. 2023; 24(13).

PMID: 37445672 PMC: 10341698. DOI: 10.3390/ijms241310495.